Early research (Phase 1)Study completedNCT04646044
What this trial is testing
A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19
Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30